Literature DB >> 16463850

Gravity valves for idiopathic normal-pressure hydrocephalus: a prospective study with 60 patients.

U Meier1.   

Abstract

OBJECTIVE: Are hydrostatic valves superior to conventional differential pressure shunts in patients with normal-pressure hydrocephalus, with regard to the postoperative results of treatment and possible complications?
METHODS: From September 1997 to January 2002, 60 patients with idiopathic normal-pressure hydrocephalus were treated by surgical implantation of hydrostatic valve at the Unfallkrankenhaus Berlin. In a prospective study, the clinical examination and a CT examination were carried out preoperatively, postoperatively and 1 year after the operation.
RESULTS: One year after the operation, the clinical picture was very good for 33% of the patients, good for 33% and satisfactory or poor for 17%, each, of the patients. 3 dislocations (5%) of ventricular or abdominal catheters and three valve infections were found as valve-independent. As valve-dependent complications, underdrainage was found in 4 patients (7%) and radiological signs of overdrainage in 2 patients (3%), while 1 patient (1.7%) showed symptomatic over-drainage.
CONCLUSION: According to our experience, hydrostatic Dual-switch valves Aesulap are superior to conventional differential pressure shunts without an additional gravity unit especially with regard to the treatment of patients with idiopathic normal-pressure hydrocephalus, concerning both the postoperative results and the incidence of possible complications. A clinical improvement can be achieved for 83% of such patients.

Entities:  

Mesh:

Year:  2005        PMID: 16463850     DOI: 10.1007/3-211-32318-x_42

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  1 in total

1.  A comparative result of ventriculoperitoneal shunt, focusing mainly on gravity-assisted valve and programmable valve.

Authors:  Won-Chul Lee; Dae-Hee Seo; Il-Seung Choe; Sung-Choon Park; Young-Soo Ha; Kyu Chang Lee
Journal:  J Korean Neurosurg Soc       Date:  2010-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.